U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets
Status: Currently in Shortage
»Date first posted: 10/12/2022
»Therapeutic Categories: Psychiatry

Expand all

Alvogen (Revised 10/20/2022)

Company Contact Information:
844-842-8672 and email CustomerService-US@alvogen.com

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5mg 100 ct (NDC 47781-174-01) Available
10mg 100 ct (NDC 47781-176-01) Available
15mg 100 ct (NDC 47781-178-01) Available
20mg 100 ct (NDC 47781-179-01) Available
30 mg 100 ct (NDC 47781-180-01) Available

Epic Pharma, LLC (New 10/12/2022)

Company Contact Information:
203-564-0568

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Amphetamine Salts 20mg C2 100 Tab (NDC 42806-344-01) Backordered
Amphetamine Salts10mg C2 100 Tab (NDC 42806-341-01) Backordered
Amphetamine Salts 15mg C2 100 Tab (NDC 42806-343-01) Backordered
Amphetamine Salts 30mg C2 100 Tab (NDC 42806-345-01) Backordered
Amphetamine Salts 5mg C2 100 Tab (NDC 42806-339-01) Backordered

Lannett Company, Inc. (New 10/12/2022)

Company Contact Information:
844-834-0530

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count (NDC 0527-1500-37) Available
7.5 mg, 100 count (NDC 0527-1501-37) Available
10 mg, 100 count (NDC 0527-1502-37) Available
12.5 mg, 100 count (NDC 0527-1503-37) Available
15 mg, 100 count (NDC 0527-1504-37) Available
20 mg, 100 count (NDC 0527-1505-37) Available
30 mg, 100 count (NDC 0527-1506-37) Available

Rhodes Pharmaceuticals L.P. (New 10/12/2022)

Company Contact Information:
888-827-0616

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, bottles of 100 tablets (NDC 42858-721-01) Unavailable Shortage of active ingredient
7.5 mg, bottles of 100 tablets (NDC 42858-722-01) Available
10 mg, bottles of 100 tablets (NDC 42858-723-01) Available
12.5 mg, bottles of 100 tablets (NDC 42858-724-01) Available

Sandoz (Reverified 12/01/2022)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
30 mg, 100 Count Bottle (NDC 0185-2099-01) Available
20 mg, 100 Count Bottle (NDC 0185-0853-01) Available
10 mg, 100 Count Bottle (NDC 0185-0842-01) Available
5 mg, 100 Count Bottle (NDC 0185-2098-01) Available

SpecGX LLC (New 10/12/2022)

Company Contact Information:
800-325-8888

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
7.5 mg 100 TABLET in 1 BOTTLE (NDC 0406-8884-01) Available
15 mg 100 TABLET in 1 BOTTLE (NDC 0406-8885-01) Available
5 mg 100 TABLET in 1 BOTTLE (NDC 0406-8891-01) Available
10 mg 100 TABLET in 1 BOTTLE (NDC 0406-8892-01) Available
20 mg 100 TABLET in 1 BOTTLE (NDC 0406-8893-01) Supply Constraints through Jan 2023
30 mg 100 TABLET in 1 BOTTLE (NDC 0406-8894-01) Supply Constraints through Jan 2023

Sunrise Pharmaceutical, Inc. (New 10/12/2022)

Company Contact Information:
732-382-6085 Monday to Friday 9 am to 3:45 pm

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Amphetamine Mixed Salts Tablets C-II 5 mg, 100 (NDC 11534-190-01) Available
Amphetamine Mixed Salts Tablets C-II 10 mg, 100 (NDC 11534-192-01) Available
Amphetamine Mixed Salts Tablets C-II 7.5 mg, 100 (NDC 11534-191-01) Available
Amphetamine Mixed Salts Tablets C-II 12.5 mg, 100 (NDC 11534-193-01) Available
Amphetamine Mixed Salts Tablets C-II 15 mg, 100 (NDC 11534-194-01) Available
Amphetamine Mixed Salts Tablets C-II 20 mg, 100 (NDC 11534-195-01) Available
Amphetamine Mixed Salts Tablets C-II 30 mg, 100 (NDC 11534-196-01) Available

Teva Pharmaceuticals (Revised 10/14/2022)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Adderall(R) Tablets 10mg 100 (NDC 57844-110-01) On backorder; Recovery expected Oct-2022 Teva has been supplying above typical forecast due to increase in market demand. Products in short supply until recovery date indicated. Other
Adderall(R) Tablets 12.5mg 100 (NDC 57844-112-01) Available Other
Adderall(R) Tablets 15mg 100 (NDC 57844-115-01) Available Other
Adderall(R) Tablets 20mg 100 (NDC 57844-120-01) Available Other
Adderall(R) Tablets 30mg 100 (NDC 57844-130-01) Available Other
Adderall(R) Tablets 5mg 100 (NDC 57844-105-01) Available Other
Adderall(R) Tablets 7.5mg 100 (NDC 57844-117-01) Available Other
12.5 mg 100 count (NDC 0555-0776-02) On backorder; Recovery expected October 2022 Teva has been supplying above typical forecast due to increase in market demand. Products in short supply until recovery date indicated. Other
15 mg 100 count (NDC 0555-0777-02) On backorder; Recovery expected November 2022 Teva has been supplying above typical forecast due to increase in market demand. Products in short supply until recovery date indicated. Other
7.5 mg 100 count (NDC 0555-0775-02) Available Other
10 mg 100 count (NDC 0555-0972-02) On backorder; Recovery expected November 2022 Teva has been supplying above typical forecast due to increase in market demand. Products in short supply until recovery date indicated. Other
20 mg 100 count (NDC 0555-0973-02) On backorder; Recovery expected November 2022 Teva has been supplying above typical forecast due to increase in market demand. Products in short supply until recovery date indicated. Other
30 mg 100 count (NDC 0555-0974-02) On backorder; Recovery expected December 2022 Teva has been supplying above typical forecast due to increase in market demand. Products in short supply until recovery date indicated. Other
5 mg 100 count (NDC 0555-0971-02) On backorder; Recovery expected November 2022 Teva has been supplying above typical forecast due to increase in market demand. Products in short supply until recovery date indicated. Other
Back to Top